Cardiac Surgery in Chronic Renal Failure

di Slaughter • 2007 • dettagli prodotto

spedizione gratuita
normalmente disponibile
per la spedizione in 10-15 giorni lavorativi
Potrebbe arrivare dopo Natale

da €82,20 a € 78,09
accedi o registrati per vedere le promozioni a te riservate

Paga gli acquisti tra 30€ e 2.000€ in 3 rate
senza interessi. Scopri di più

Aggiungi al carrello
Aggiungi alla lista dei desideri

DESCRIZIONE

“The work focuses on a phenomenon that is occurring with increasing frequency in the practice of cardiac surgery, namely the need to address cardiac surgical issues in patients with end-stage renal disease (ESRD). . . . this book will serve to stimulate trials of competing and complementary therapies so that the outcomes for these unfortunate patients can be improved.”-- from the Foreword by R. Morton Boltman, III, MDProfessor of Surgery, Harvard Medical SchoolChief, Cardiac Surgery, Brigham and Women’s Hospital, BostonCardiovascular disease remains the most common cause of death for patients with chronic renal failure, and although cardiac surgery can frequently relieve symptoms and prolong survival, it is still associated with significant complications. This concise volume draws on the expertise of leading specialists to help practitioners and trainees understand the full range of current treatment options and their outcomes. Noted authorities such as Charles A. Herzog and William Cohn share both their insights and their technical tips, developed through years of experience.Cardiac Surgery in Chronic Renal Failure includes chapters on:• the impact of ESRD in society• percutaneous coronary revascularization in ESRD patients• cardiopulmonary bypass in patients with chronic renal failure• coronary bypass grafting in ESRD patients requiring dialysis• surgical treatment of valvular heart disease in ESRD patients• surgical evaluation and treatment of uremic pericarditisPracticing nephrologists and cardiologists, as well as residents and fellows, will find this important volume serves as a guide to achieving the best possible outcomes and a call to reduce the impact of cardiovascular disease in ESRD